|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 106, Issue 3 543-554, Copyright © 1989 by Company of Biologists
JOURNAL ARTICLES |
AL Brice, JE Cheetham, VN Bolton, NC Hill and PN Schofield
Department Zoology, University of Oxford, UK.
The insulin-like growth factors are broadly distributed in the human conceptus and are thought to play a role in the growth and differentiation of tissues during development. Using in situ hybridization we have shown that a wide variety of specific cell types within tissues express the gene for insulin-like growth factor II at times of development from 18 days to 14 weeks of gestation. Examination of blastocysts produced by in vitro fertilization showed no expression, thus bracketing the time of first accumulation of IGF-II mRNA to between 5 and 18 days postfertilization. The pattern of IGF-II expression shows specific age-related differences in different tissues. In the kidney, for example, expression is found in the cells of the metanephric blastema which is dramatically reduced as the blastema differentiates. The reverse is also seen, and we have noted an increase in expression of IGF-II in the cytotrophoblast layer of the placenta with gestational age. The sites of expression do not correlate with areas of either high mitotic activity or specific types of differentiation, but the observed pattern of expression in the kidney, adrenal glands and liver suggests an explanation for the abnormally high IGF-II mRNA expression in developmental tumours such as Wilms' tumour.
This article has been cited by other articles:
|
|
 |
|
  D. K. Tisi, X.-J. Liu, L. J. Wykes, C. D. Skinner, and K. G. Koski Insulin-Like Growth Factor II and Binding Proteins 1 and 3 from Second Trimester Human Amniotic Fluid Are Associated with Infant Birth Weight J. Nutr., July 1, 2005; 135(7): 1667 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Westwood, J.M. Gibson, S. R. Sooranna, S. Ward, J. P. Neilson, and R. Bajoria Genes or placenta as modulator of fetal growth: evidence from the insulin-like growth factor axis in twins with discordant growth Mol. Hum. Reprod., April 1, 2001; 7(4): 387 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Granérus, A Johannisson, P Ekblom, and W Engström Insulin-like growth factors I and II induce cell death in Wilms's tumour cells Mol. Pathol., February 1, 2001; 54(1): 30 - 35. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Nielsen, J. Christiansen, J. Lykke-Andersen, A. H. Johnsen, U. M. Wewer, and F. C. Nielsen A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development Mol. Cell. Biol., February 1, 1999; 19(2): 1262 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Paquette, N. Giannoukakis, C. Polychronakos, P. Vafiadis, and C. Deal The INS 5' Variable Number of Tandem Repeats Is Associated with IGF2 Expression in Humans J. Biol. Chem., June 5, 1998; 273(23): 14158 - 14164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Ohlsson, F Hedborg, L Holmgren, C Walsh, and T. Ekstrom Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression Development, January 2, 1994; 120(2): 361 - 368. [Abstract] [PDF]
|
|
|
|
 |
|
 D A Rappolee, K S Sturm, O Behrendtsen, G A Schultz, R A Pedersen, and Z Werb Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes & Dev., June 1, 1992; 6(6): 939 - 952. [Abstract] [PDF]
|
|
|
|
 |
|
 T Glaser, J Lane, and D Housman A mouse model of the aniridia-Wilms tumor deletion syndrome Science, November 9, 1990; 250(4982): 823 - 827. [Abstract] [PDF]
|
|
